Proteonomix, Inc. (OTCPK:PROT)
Proteonomix, Inc., a biotechnology company focused on developing therapeutics based upon the use of human cells and their derivatives, is pleased to provide an update on PROT's addition to its Board of Directors. PROT is pleased to announce that Ian McNiece has been appointed to the Proteonomix Board of Directors. Dr. McNiece, has served as Vice-President for Scientific Development and Chief Scientific Officer since November 11, 2009. He received his PhD in 1986 from the University of Melbourne undertaking his thesis work in studies of blood cell development at the Peter MacCallum Cancer Institute in Melbourne, Australia. He moved to the United States in July, 1986 to the University of Virginia as a postdoctoral fellow. In August, 1997 he was employed by Amgen, Inc, as a Research Scientist and then as a Laboratory Head. In September 1998, he left Amgen and moved to the University of Colorado as the Director of Research in the Bone Marrow Transplant Program. Subsequently, he joined JHU as a Professor of Oncology and Laboratory Director of the Graft Engineering Laboratory from January 2003 to May 2007. This laboratory is responsible for all processing of bone marrow, peripheral blood progenitor cell (PBPC) products and cord blood products for transplantation of cancer patients. He was actively involved in optimization of cellular grafts for patient treatment and the translation of basic research to clinical treatment. In July, 2007 he joined the Stem Cell Institute at U Miami as Director of the Experimental and Clinical Cell-Based Therapies and is presently Professor of Medicine at U Miami. Dr. McNiece on January 2, 2007 became a member of the Scientific Advisory Board and Chief Scientific Officer of Proteonomix.
Mr. Michael Cohen, Chairman and CEO of PROT, noted, "The elevation of Dr. McNiece to the Board will allow Ian to play a greater role in developing corporate policy especially as it relates to the development and procurement of Intellectual policy ('IP'). Further, as BOD member, Dr. McNiece will have the ability to influence the development of other business strategies that affect the current portfolio of IP."
Dr. McNiece stated, "I look forward to serving on the Board of Directors and expediting the development and commercialization of our current and future products, especially as this relates to the Proteonomix portfolio of clinical applications."
To learn more about PROT visit: http://www.proteonomix.com
National Technical Systems Inc. (Nasdaq:NTSC) a leading provider of engineering services, announced that it has completed the acquisition of privately-held Mechtronic Solutions, Inc. (NYSE:MSI). With annual revenues of approximately $7.5 million, MSI is a multi-skilled engineering services company with an extensive customer base in the aerospace and defense industries. Terms of the transaction were not disclosed. Albuquerque, NM-based MSI was founded in 1993 as a mechanical engineering consultancy and has grown to a staff of sixty personnel offering mechanical, electrical and software engineering as well as in-house machining, electronics assembly and full system integration.
National Technical Systems, Inc., a diversified technical services company, provides engineering and compliance testing services to the defense, aerospace, telecommunications.
Global Hunter Corp. recently announced the results from the first 91.8 metres of core drilled in hole RS-D-08-123 averaging 0.070 percent molybdenum and 0.13 grams per tonne rhenium. The molybdenum grade is 8.3 percent higher than the grade from the same interval in twinned hole RS-D-80-56. None of the previous operators had analyzed for rhenium.
Rabbit South, British Columbia:
1,900 hectare land package between two of British Columbia's most successful copper mines (Afton and Highland Valley)
La Corona de Cobre, Chile:
+18,000 hectare land package in coastal belt of Andean Cordillera of Chile on the Atacama Fault Zone ("Chilean Iron-Copper Belt")
To learn more about Global Hunter visit: http://www.globalhunter.ca
Primoris Services Corporation (Nasdaq:PRIM) one of the largest specialty contractors and infrastructure companies in the United States, announced its eligibility for inclusion in the NASDAQ Global Select Marketsm, the highest of the three market tiers designated by The NASDAQ Stock Market. Primoris's selection follows an annual review by NASDAQ to determine which companies meet the more stringent listing requirements of The NASDAQ Global Select Market. According to NASDAQ, its Global Select Market is reserved for "...public companies that meet the highest listing standards in the world." Primoris's securities will be listed on The NASDAQ Global Select Market effective January 3, 2011.
Primoris Services Corporation, through its subsidiaries, provides construction, fabrication, maintenance, replacement, and engineering services to public utilities, petrochemical companies, energy companies, and municipalities primarily in the United States and Canada.
JA Solar Holdings Co., Ltd. (Nasdaq:JASO) one of the world's largest manufacturers of high-performance solar cells and solar power products, announced a partnership and supply agreement with tenKsolar, Inc., a Minnesota-based solar technology company. Under the agreement, JA Solar will supply its high-efficiency "SECIUM" solar cell technology for use in tenKsolar's RAIS(NYSE:R) rooftop array. When deployed in the tenKsolar RAIS(R) array using static reflection as a proprietary cell-optimizing architecture.
JA Solar Holdings Co., Ltd., through its subsidiaries, engages in the development, production, and marketing of photovoltaic solar cells, which convert sunlight into electricity in the People's Republic of China.
Signup for FREE Daily Stock Alerts From CRWEFinance.com/signup
THIS IS NOT A RECOMMENDATION TO BUY OR SELL ANY SECURITY!
Disclaimer: Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. CRWEFinance.com publisher and its affiliates and contractors are not registered investment advisers or broker/dealers. Our disclaimer is to be read and fully understood before using our site, reading our newsletter or joining our email list. Release of Liability: Through use of this website viewing or using, you agree to hold CRWEFinance.com report and Crown Equity Holdings Inc. CRWE, its operators, shareholders, employees and/or contractors harmless and to completely release them from any and all liability due to any and all loss (monetary or otherwise), damages (monetary or otherwise) that you may occur. (Read more at http://crwefinance.com/disclaimer) Rule 17B requires disclosure of payment for investor relations. Crown Equity Holdings Inc. (OTCPK:CRWE) is a newswire as well as an IR and PR firm. Crown Equity Holdings Inc. (OTCPK:CRWE), in some cases, provides media advertising and public awareness for both public and private companies, as well as disseminating news. As such, in some cases, when Crown Equity Holdings Inc. (OTCPK:CRWE) advertises for a particular client, Crown Equity Holdings Inc. (OTCPK:CRWE) charges an advertising fee which it must disclose under 17B. The fee may be in cash, in free trading stock or in restricted stock. Crown Equity Holdings Inc. (OTCPK:CRWE), if paid in stock, can and may sell those securities during the advertising period. Crown Equity Holdings Inc. (OTCPK:CRWE) has received twenty-five thousand dollars in cash from Global Hunter Corp. (TSX Venture Exchange (TSX.VOB) and the Frankfurt Stock Exchange (FSE:G5D)) for 30 (thirty) days of advertising, as well as for assistance in becoming a fully reporting publicly trading Bulletin Board company. Crown Equity Holdings Inc. (OTCPK:CRWE) has previously received twenty thousand dollars in cash and twenty thousand dollars in free trading shares from a third party (Swiss Financial Report) for (30) days of advertisement services (which has expired) for Proteonomix, Inc. (OTCPK:PROT).